About Virologik
ViroLogik GmbH is engaged in the development, testing and marketing of new drugs and therapies against viral infectious diseases. The company uses patented methods to influence the interaction of cellular and viral factors. The novel therapeutic approaches are to be applied in the treatment of infections with viruses which, due to their high mutation frequency, tend to be resistant to the classical forms of therapy directed against the virus [in particular human immunodeficiency viruses (HIV) influenza A viruses (IAV) and hepatitis C and B viruses (HB/CV)].
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Pharma
